CN109157519B - Preparation method of ofloxacin tablets - Google Patents

Preparation method of ofloxacin tablets Download PDF

Info

Publication number
CN109157519B
CN109157519B CN201810597995.2A CN201810597995A CN109157519B CN 109157519 B CN109157519 B CN 109157519B CN 201810597995 A CN201810597995 A CN 201810597995A CN 109157519 B CN109157519 B CN 109157519B
Authority
CN
China
Prior art keywords
ofloxacin
preparation
materials
moisture content
mixing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201810597995.2A
Other languages
Chinese (zh)
Other versions
CN109157519A (en
Inventor
刘登
朱典成
王路
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Polytechnic College
Original Assignee
Shandong Polytechnic College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Polytechnic College filed Critical Shandong Polytechnic College
Priority to CN201810597995.2A priority Critical patent/CN109157519B/en
Publication of CN109157519A publication Critical patent/CN109157519A/en
Application granted granted Critical
Publication of CN109157519B publication Critical patent/CN109157519B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of pharmaceutical preparations, and relates to a method for preparing non-sticking ofloxacin tablets aiming at the defect of sticking of ofloxacin materials. The tablet disclosed by the invention has the advantages of simple preparation method, easiness in industrialization, controllable quality, high production efficiency and the like, can be produced by adopting a conventional preparation method, does not need special equipment, and is obviously improved.

Description

Preparation method of ofloxacin tablets
Technical Field
The invention relates to the field of pharmaceutical preparations, in particular to a tablet containing ofloxacin and a preparation method thereof.
Background
Ofloxacin is a quinolone antibacterial drug, and acts on A subunit of bacterial DNA helicase to inhibit DNA synthesis and replication, so that the bacteria die. Chemical name of ofloxacin: (±) -9-fluoro-2, 3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de]-[1,4]Benzoxazine-6-carboxylic acid, formula: c18H20FN3O4 Molecular weight: 361.38 has the chemical structural formula:
Figure 212963DEST_PATH_IMAGE001
the ofloxacin molecules contain carboxyl, the carboxyl can be tightly combined with stainless steel equipment under the catalysis of moisture to cause sticking, the ofloxacin tablet has the specification of 0.1g and accounts for about 50% of the whole tablet, the sticking phenomenon is serious in the tabletting process, the problem of sticking of the ofloxacin tablet cannot be solved due to the fact that the content of the raw material of the ofloxacin is high, the effect of adding magnesium stearate serving as a lubricant is not large, the problem of sticking of the ofloxacin tablet cannot be solved due to the fact that the type of the lubricant is changed, the traditional production method is to continuously stop equipment to clean a punch, the production efficiency is low, and the product quality cannot be guaranteed.
At present, a patent about solving the sticking problem of the ofloxacin tablet is not found, and a Chinese patent (application number 20131025966.3) discloses a method for solving the sticking problem, and discloses a sticking and punching gap bridge device for a tablet press, which needs to be modified. Other methods for solving the sticking problem of oral solid preparations comprise adopting a special adhesive (CN 2014I 10735866) and treating the raw materials with a special solvent in advance (CN 105380916), and Chinese patent application No. 201410652944.7 discloses an ofloxacin dispersible tablet, which does not mention the method provided by the invention, and treats the materials from the aspect of preparation process to solve the sticking problem.
The invention aims to provide an ofloxacin tablet and a preparation method thereof, which solve the sticking problem in the preparation process, improve the product quality and improve the production efficiency.
Disclosure of Invention
Aiming at the problems, the invention provides a preparation method of an ofloxacin tablet. The ofloxacin tablet provided by the invention contains pharmaceutically acceptable filler, adhesive, disintegrant and lubricant.
Preferably, the pharmaceutical composition provided by the invention consists of ofloxacin, corn starch, sodium carboxymethyl starch, hydroxypropyl methylcellulose and magnesium stearate.
The invention prepares the non-sticking ofloxacin tablet by the following method: mixing ofloxacin raw material and adjuvant, adding adhesive, and mixing. The mixed materials are firstly dried in advance in one step. The granules treated in this step were not sticky during tabletting. The pre-dried material is then granulated in a granulator, finally dried and compressed into tablets.
The invention also provides a preparation method of the oxyfluorsaxate tablet, which comprises the following steps:
adding ofloxacin, corn starch and sodium carboxymethyl starch into a mixing device, and uniformly mixing.
Secondly, adding a water-alcohol mixed solution of hydroxypropyl methylcellulose with certain concentration into the materials obtained in the first step, and uniformly mixing.
Thirdly, the materials obtained in the second step are pre-dried by a fluidized bed, and the end point is 3 to 15 percent (preferably 5 to 8 percent) of the moisture of the materials
And fourthly, granulating the materials which are dried in advance in the third step by using a granulator.
Fifthly, drying the material obtained in the fourth step, and adding magnesium stearate.
Sixthly, tabletting.
The specific implementation content is as follows:
example (b):
prescription:
name (R) Amount of prescription
Ofloxacin 1000g
Corn starch 900g
Sodium starch glycolate 70g
2.5% hydroxypropyl methylcellulose in 50% ethanol 800ml (hydroxypropyl methylcellulose: 20 g)
Magnesium stearate 30g
Total weight of 2020g
Amount of preparation 10000 tablets
The preparation process comprises the following steps:
adding prescription dose of ofloxacin, corn starch and sodium carboxymethyl starch into a wet granulator, mixing for 10 minutes at 70rpm, and mixing uniformly.
② adding adhesive with prescription amount, stirring at 70rpm, cutting at 1500rpm, and mixing uniformly.
And thirdly, placing the wet material obtained in the second step into fluidized bed drying equipment, controlling the air inlet temperature to be 75 ℃, setting the frequency of a fan to be 20HZ, drying for about 10 minutes, discharging, taking particles, measuring moisture, controlling the moisture to be 7%, and stopping drying the material.
Fourthly, granulating the materials obtained in the third step by using a 16-mesh sieve, and drying the granules in the fluidized bed again until the water content is 3 percent.
Fifthly, adding the magnesium stearate with the amount of the prescription into the dried material, mixing uniformly and tabletting.
Drug stability study
Figure 588188DEST_PATH_IMAGE002
The ofloxacin tablet prepared by the invention has no sticking problem in the tabletting process, the content of the provided ofloxacin tablet is accelerated for 6 months, the change of related substances is not large, and the product stability is good.

Claims (3)

1. A preparation method of tablets containing ofloxacin is characterized in that: the prescription composition of every ten thousand ofloxacin tablets is as follows: 1000g of ofloxacin, 900g of corn starch, 70g of sodium carboxymethyl starch, 20g of hydroxypropyl methylcellulose and 30g of magnesium stearate;
the preparation method of the oxyfluorsaxate tablet comprises the following steps:
adding prescription dose of ofloxacin, corn starch and sodium carboxymethyl starch into a wet granulator, mixing for 10 minutes at 70rpm, and uniformly mixing;
secondly, dissolving the hydroxypropyl methylcellulose with the prescription amount in 800ml of 50% ethanol solution, adding the solution into the mixed material obtained in the first step, stirring the mixed material at 70rpm, and uniformly mixing the mixed material by a cutter at 1500 rpm;
thirdly, placing the materials obtained in the second step into fluidized bed drying equipment, controlling the air inlet temperature to be 75 ℃ and the frequency of a fan to be 20HZ, and pre-drying the materials until the moisture content of the materials is 3% -15%;
fourthly, after the materials obtained in the third step are granulated by 16 meshes, the granules are put into a fluidized bed again for drying until the moisture content is 3 percent;
fifthly, adding the magnesium stearate with the prescription amount into the material obtained in the fourth step, mixing uniformly and tabletting.
2. The preparation method of claim 1, wherein the predrying end point is that the moisture content of the material is 5% -8%;
3. the method according to claim 1, wherein the predrying end point is a material moisture content of 7%.
CN201810597995.2A 2018-06-12 2018-06-12 Preparation method of ofloxacin tablets Expired - Fee Related CN109157519B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810597995.2A CN109157519B (en) 2018-06-12 2018-06-12 Preparation method of ofloxacin tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810597995.2A CN109157519B (en) 2018-06-12 2018-06-12 Preparation method of ofloxacin tablets

Publications (2)

Publication Number Publication Date
CN109157519A CN109157519A (en) 2019-01-08
CN109157519B true CN109157519B (en) 2021-01-26

Family

ID=64897108

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810597995.2A Expired - Fee Related CN109157519B (en) 2018-06-12 2018-06-12 Preparation method of ofloxacin tablets

Country Status (1)

Country Link
CN (1) CN109157519B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113368072A (en) * 2021-06-23 2021-09-10 海南海神同洲制药有限公司 Ofloxacin coated tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104257612A (en) * 2014-09-04 2015-01-07 河南亚卫动物药业有限公司 Long-acting ofloxacin sustained-release pellet for veterinary use and preparation method thereof
CN104288112A (en) * 2014-09-30 2015-01-21 地奥集团成都药业股份有限公司 Levofloxacin hydrochloride tablets
CN105796523A (en) * 2016-04-19 2016-07-27 湖北午时药业股份有限公司 Levofloxacin mesylate tablets and preparation process thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104257612A (en) * 2014-09-04 2015-01-07 河南亚卫动物药业有限公司 Long-acting ofloxacin sustained-release pellet for veterinary use and preparation method thereof
CN104288112A (en) * 2014-09-30 2015-01-21 地奥集团成都药业股份有限公司 Levofloxacin hydrochloride tablets
CN105796523A (en) * 2016-04-19 2016-07-27 湖北午时药业股份有限公司 Levofloxacin mesylate tablets and preparation process thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
氧氟沙星片工艺的研究;林惠安等;《广东药学》;20021231;第12卷(第4期);第22-24页 *

Also Published As

Publication number Publication date
CN109157519A (en) 2019-01-08

Similar Documents

Publication Publication Date Title
CN104523640A (en) Ticagrelor tablets and preparation method thereof
CN109157519B (en) Preparation method of ofloxacin tablets
Shende et al. Studies on development of Sustained release Diltiazem hydrochloride matrices through jackfruit mucilage
CN104055743A (en) Preparation method of oral preparation containing rivaroxaban
CN115025066B (en) Preparation method of traditional Chinese medicine slow-release particles with stable quality and capable of resisting diarrhea of piglets
CN101822650A (en) Minocycline hydrochloride sustained release tablet and preparation method thereof
CN111297867A (en) Use of composition containing pyridylaminopyridopyrimidine derivative for preparing medicine for treating breast cancer
CN103263395A (en) Telmisartan tablet preparation and preparation method thereof
CN110664771A (en) Pharmaceutical composition containing pexaparib hydrochloride and preparation method thereof
CN104800177B (en) A kind of Cefadroxil tablets and preparation method thereof
CN103977009A (en) Orally-taken medicinal composition containing cefdinir and preparation method thereof
CN102526007A (en) Florfenicol taste masking preparation and preparation method for same
CN114748435A (en) Donepezil hydrochloride orally disintegrating tablet and preparation method thereof
CN110420190B (en) Clonazepam tablets and preparation method thereof
CN104161734A (en) Amoxicillin dispersible tablet as well as preparation method and use thereof
CN103479589A (en) Cefpodoxime proxetil dispersible tablet and preparation method thereof
CN105030707B (en) Method for preparing clotrimazole buccal tablets based on modified glucose whole powder direct compression method
CN116555499A (en) Compressible sucrose particles and method for preparing same
CN115487158A (en) Cytisine tablet and preparation method thereof
CN110051639B (en) Rapidly disintegrating nicergoline tablet and preparation method thereof
CN103816129B (en) Agomelatine orally disintegrating tablet
CN110876728A (en) Preparation method of metformin hydrochloride quick-release preparation
CN104666263A (en) Tablet containing levetiracetam and preparation method of tablet
CN103340856A (en) Rifaximin medicine composition and preparation method thereof
CN115624535B (en) Preparation method of Fudosteine tablet

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210126

Termination date: 20210612

CF01 Termination of patent right due to non-payment of annual fee